Compounds > 1-phenyl-2-decanoylamino-3-morpholino-1-propanol

1-phenyl-2-decanoylamino-3-morpholino-1-propanol and deoxycytidine

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with deoxycytidine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barth, BM; Cabot, MC; Cheng, H; DiVittore, NA; Fox, TE; Fritz, JL; Heakal, Y; Jiang, Y; Kaiser, JM; Kester, M; Shanmugavelandy, SS; Staveley-O'Carroll, KF; Tagaram, HR; Tran, MA	1

Other Studies

1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and deoxycytidine

Article	Year
Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer. Cancer biology & therapy, 2011, Oct-01, Volume: 12, Issue:7 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Ceramides; Deoxycytidine; Drug Carriers; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Female; Gemcitabine; Glucosyltransferases; Humans; Liposomes; MAP Kinase Signaling System; Mice; Mice, Nude; Morpholines; Nanoparticles; Pancreatic Neoplasms; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays	2011

Article

Year

Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer.

Cancer biology & therapy, 2011, Oct-01, Volume: 12, Issue:7

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Ceramides; Deoxycytidine; Drug Carriers; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Female; Gemcitabine; Glucosyltransferases; Humans; Liposomes; MAP Kinase Signaling System; Mice; Mice, Nude; Morpholines; Nanoparticles; Pancreatic Neoplasms; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays

2011